Sign in
Cell Therapies for Atrophic AMD
Allen C Ho, MD FASRS
Updates from the Field
2020
Beyond Complement: A Novel FAS Inhibition Approach for Neuroprotection in GA
Vaidehi S. Dedania, MD
2024
One Year and Beyond: Results of Phase 1b Study of KSI-301, an AntiVEGF Antibody Biopolymer Conjugate With Extended Durability, in wAMD, DME, and RVO
Mark R. Barakat, MD
Category: AMD-Non-Neovascular